Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Probing the correlation of neuronal loss, neurofibrillary tangles, and cell death markers across the Alzheimer's disease Braak stages: a quantitative study in humans
Panos Theofilas, Alexander J. Ehrenberg, Austin Nguy, et al.
Neurobiology of Aging (2017) Vol. 61, pp. 1-12
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Neuronal Cell Death Mechanisms in Major Neurodegenerative Diseases
Hao Ran, Hui-Yun Chang, Tzu‐Kang Sang
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3082-3082
Open Access | Times Cited: 347
Multi-modal deep learning model for auxiliary diagnosis of Alzheimer’s disease
Fan Zhang, Zhenzhen Li, Boyan Zhang, et al.
Neurocomputing (2019) Vol. 361, pp. 185-195
Closed Access | Times Cited: 175
The role of noradrenaline in cognition and cognitive disorders
Negin Holland, Trevor W. Robbins, James B. Rowe
Brain (2021) Vol. 144, Iss. 8, pp. 2243-2256
Open Access | Times Cited: 132
The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer’s disease
Billie J. Matchett, Lea T. Grinberg, Panos Theofilas, et al.
Acta Neuropathologica (2021) Vol. 141, Iss. 5, pp. 631-650
Open Access | Times Cited: 117
Probing locus coeruleus functional network in healthy aging and its association with Alzheimer’s disease biomarkers using pupillometry
Junjie Wu, A. Toporek, Qixiang Lin, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Cholesterol and Alzheimer’s Disease Risk: A Meta-Meta-Analysis
Olalla Sáiz-Vazquez, Alicia Puente‐Martinez, Silvia Ubillos Landa, et al.
Brain Sciences (2020) Vol. 10, Iss. 6, pp. 386-386
Open Access | Times Cited: 99
An Effective Multimodal Image Fusion Method Using MRI and PET for Alzheimer's Disease Diagnosis
Juan Song, Jian Zheng, Ping Li, et al.
Frontiers in Digital Health (2021) Vol. 3
Open Access | Times Cited: 90
The endoplasmic reticulum stress and unfolded protein response in Alzheimer’s disease: A calcium dyshomeostasis perspective
Dmitry Lim, Laura Tapella, Giulia Dematteis, et al.
Ageing Research Reviews (2023) Vol. 87, pp. 101914-101914
Open Access | Times Cited: 38
Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer’s disease
Kanza M. Khan, Nagalakshmi Balasubramanian, Gabriel Gaudencio, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 23
The Molecular Mechanisms of Neuroinflammation in Alzheimer’s Disease, the Consequence of Neural Cell Death
Su-Bin Choi, Sehee Kwon, Jihye Kim, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11757-11757
Open Access | Times Cited: 23
Specificity for latent C termini links the E3 ubiquitin ligase CHIP to caspases
Matthew Ravalin, Panagiotis Theofilas, Koli Basu, et al.
Nature Chemical Biology (2019) Vol. 15, Iss. 8, pp. 786-794
Open Access | Times Cited: 68
Disturbances of sleep quality, timing and structure and their relationship with other neuropsychiatric symptoms in Alzheimer’s disease and schizophrenia: Insights from studies in patient populations and animal models
Raphaëlle Winsky‐Sommerer, Paula de Oliveira, Sally Loomis, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 97, pp. 112-137
Open Access | Times Cited: 63
Heightened Hippocampal β-Adrenergic Receptor Function Drives Synaptic Potentiation and Supports Learning and Memory in the TgF344-AD Rat Model during Prodromal Alzheimer's Disease
Anthoni M. Goodman, Bethany M. Langner, Nateka L. Jackson, et al.
Journal of Neuroscience (2021) Vol. 41, Iss. 26, pp. 5747-5761
Open Access | Times Cited: 47
Multi-Modal Biomarkers of Repetitive Head Impacts and Traumatic Encephalopathy Syndrome: A Clinicopathological Case Series
Breton M. Asken, Jeremy A. Tanner, Lawren VandeVrede, et al.
Journal of Neurotrauma (2022) Vol. 39, Iss. 17-18, pp. 1195-1213
Open Access | Times Cited: 30
Cerebrospinal fluid: A specific biofluid for the biosensing of Alzheimer's diseases biomarkers
Arezoo Mirzaie, Hassan Nasrollahpour, Balal Khalilzadeh, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 166, pp. 117174-117174
Closed Access | Times Cited: 17
Advance Convolutional Network Architecture for MRI Data Investigation for Alzheimer's Disease Early Diagnosis
Nilanjana Pradhan, Shrddha Sagar, T. Jagadesh
SN Computer Science (2024) Vol. 5, Iss. 1
Closed Access | Times Cited: 7
Selective Vulnerability of Brainstem Nuclei in Distinct Tauopathies: A Postmortem Study
Rana Eser, Alexander J. Ehrenberg, Cathrine Petersen, et al.
Journal of Neuropathology & Experimental Neurology (2018) Vol. 77, Iss. 2, pp. 149-161
Open Access | Times Cited: 55
Impaired Phasic Discharge of Locus Coeruleus Neurons Based on Persistent High Tonic Discharge—A New Hypothesis With Potential Implications for Neurodegenerative Diseases
Kathrin Janitzky
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 44
Advances in the development paradigm of biosample‐based biosensors for early ultrasensitive detection of alzheimer’s disease
Hem Prakash Karki, Yeongseok Jang, Jinmu Jung, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 35
Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies
Cody Slater, Qi Wang
Clinical and Translational Medicine (2021) Vol. 11, Iss. 4
Open Access | Times Cited: 33
Electrochemical aptamer-based nanobiosensors for diagnosing Alzheimer's disease: A review
Masoud Negahdary, Lúcio Angnes
Biomaterials Advances (2022) Vol. 135, pp. 112689-112689
Closed Access | Times Cited: 27
Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target
Irene L. Gutiérrez, Cinzia Dello Russo, Fabiana Novellino, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6143-6143
Open Access | Times Cited: 27
Orthogonal latent space learning with feature weighting and graph learning for multimodal Alzheimer’s disease diagnosis
Zhi Chen, Yongguo Liu, Yun Zhang, et al.
Medical Image Analysis (2022) Vol. 84, pp. 102698-102698
Open Access | Times Cited: 25
Necroptosis and Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Opportunities
Ruxin Zhang, Yanrong Song, Xuefeng Su
Journal of Alzheimer s Disease (2022) Vol. 94, Iss. s1, pp. S367-S386
Open Access | Times Cited: 25
NLRP1 Inflammasome Activation in the Hippocampal Formation in Alzheimer’s Disease: Correlation with Neuropathological Changes and Unbiasedly Estimated Neuronal Loss
Ena Španić, Lea Langer Horvat, Katarina Ilić, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2223-2223
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top